Just - Evotec Biologics

Just - Evotec Biologics is a CDMO offering development and cGMP manufacturing services for antibody, next-generation biologics, and biosimilar products. It partners with clients on antibody discovery, development, process development and biomanufacturing projects, and applies expertise in continuous manufacturing to technologies designed to reduce cost of goods and help expand global access to affordable, high-quality biotherapeutics. Its integrated end-to-end continuous manufacturing process platform is highly intensified and allows significantly more product in a smaller footprint than traditional batch manufacturing. Its award-winning GMP facility design, called J.POD, houses the highly automated continuous process in modular clean room pods; these facilities are smaller, more cost-effective, and faster to build than traditional facilities and can produce up to two metric tons of product per year. Just - Evotec Biologics operates two manufacturing sites in Seattle and Redmond, WA, offering cell line, analytical, and process development services as well as early clinical to commercial cGMP biologics manufacturing services under one roof. It is part of the Evotec group.

Just - Evotec Biologics is a CDMO offering development and cGMP manufacturing services for antibody, next-generation biologics, and biosimilar products. It partners with clients on antibody discovery, development, process development and biomanufacturing projects. By applying expertise in continuous manufacturing, it has designed technologies to reduce cost of goods and help expand global access to affordable, high-quality biotherapeutics. It has developed an innovative integrated end-to-end continuous manufacturing process platform that is highly intensified and allows it to make significantly more product in a smaller footprint than traditional batch manufacturing. Its optimized bioprocess platform continuously purifies antibodies and recombinant proteins from perfusion cell culture bioreactors, leading to higher product quality. The small footprint of its end-to-end continuous process enables a significant reduction in the size of the manufacturing plant. Its award-winning GMP facility design, called J.POD, houses its highly automated continuous process in modular clean room pods; these biomanufacturing facilities are smaller, more cost-effective, and faster to build than traditional facilities, and can produce up to two metric tons of product per year despite their small size. Just - Evotec Biologics operates two manufacturing sites in Seattle and Redmond, WA, offering cell line, analytical, and process development services as well as early clinical to commercial cGMP biologics manufacturing services all under one roof. It offers partnership opportunities at every step of the development phase, from discovery to market supply, and forms collaborations based on transparency, trust and shared success. Its platform is described as a fit for discovery and CMC/First-In-Human activities as well as later clinical stages, and it can coordinate preclinical/toxicology packages through the global Evotec capabilities if required. It benefits from the strong expertise of the Evotec group in setting up fully integrated discovery, preclinical and CMC programs, and leverages its advanced end-to-end continuous manufacturing platform to support late clinical phase and commercial pipeline with flexible supply chain and lowest COGS manufacturing options. The combined performance, agility and cost-efficiency of its platform positions it as a partner of choice for pandemic preparedness with governments and non-profit organizations. It is part of the Evotec group, a drug discovery and development company.

A CDMO applying continuous manufacturing expertise to reduce cost of goods and help expand global access to affordable, high-quality biotherapeutics; its platform is described as a partner of choice for pandemic preparedness with governments and non-profit organizations.

• Integrated end-to-end continuous manufacturing process platform

  A highly intensified platform that allows significantly more product in a smaller footprint than traditional batch manufacturing; it continuously purifies antibodies and recombinant proteins from perfusion cell culture bioreactors.

• J.POD

  An award-winning GMP facility design that houses the highly automated continuous process in modular clean room pods; these facilities are smaller, more cost-effective, and faster to build than traditional facilities and can produce up to two metric tons of product per year.

1. 1Global Access to Biotherapeutics | Just - Evotec Biologicsevotec.com
2. 2Our Company | Evotecevotec.com
3. 3Working at Evotec | Jobs & Careers at the Evotec Groupcareers.evotec.com
4. 4Partnering for Biologics Discovery, Development & Manufacturing- Just - Evotec Biologicsevotec.com